Approval · Notice of Compliance 3375 · 2003
SYNAREL: Notice of Compliance 3375
Issued October 6, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3375
- Date
- October 6, 2003
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Gonadotropin releasing hormone (gnrh) analogue
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SYNAREL | 02188783 | Marketed |
Medicinal ingredients
- NAFARELIN ACETATE 2 MG per ML